During the years 1997 to 1999, the rate of complications after augmentation rhinoplasty with e-PTFE (Gore-Tex) was as high as 13% in our experience (which was published in a domestic journal in 2001). At that time, augmentation rhinoplasty with e-PTFE was based on the technique used for augmentation rhinoplasty with silicone; eg, the e-PTFE prosthesis was inserted into the tunnel of the dorsum through a small incision in the nostril, frequently causing distortion of the prosthesis. Furthermore, to achieve a better result than that with the silicone prosthesis, a larger-size e-PTFE prosthesis was often used, especially in the nasal tip, which can increase the instability of the prosthesis position and cause higher surface tension of the nasal skin. However, because the shape of the e-PTFE prosthesis was difficult to predict, many complications occurred after surgery. Even now, many plastic surgeons in China have performed augmentation rhinoplasty only with the silicone prosthesis rather than with the e-PTFE prosthesis. A recent review of the literature revealed several reports that have introduced improved techniques that could reduce the complications of augmentation rhinoplasty with e-PTFE in China. It is clear that there is a higher complication rate in augmentation rhinoplasty with e-PTFE. According to the analysis, one of the main reasons is that the prosthesis can migrate, which increases the surface tension of local skin or mucosa,2,3 causing skin redness, swelling, hardening, or purple discoloration (mostly in the tip of the nose and the dorsal area) on postoperative day 1 or 2. The red spot radiates to the surrounding skin within 1 week, and, at that time, the typical signs and symptoms of infection are redness, swelling, heat, and pain. Weeks or months after surgery, the prodromal phase of infection of an e-PTFE implantation develops with the signs of prosthesis migration, which could manifest with a red node in some areas (mostly in and around the collumellar incision). Then, the red node develops either an ulceration or a recurrent inflammatory response, which could continue for several months or longer and will not improve with antibiotic therapy. Usually, a granuloma and partial extrusion of the prosthesis will develop. The inflammation cannot be controlled unless the prosthesis is removed. According to the retrospective analysis, pure infection has typical symptoms: there are signs of redness, edema, heat, and pain on the whole area of the nose 3 days after surgery, which gradually become more severe.4 Therefore, we designed the following 4 principles for e-PTFE rhinoplasty procedures: prevent infection, control operative bleeding and edema, decrease the surface tension of the prosthesis, and stabilize the position of prosthesis. The goals were not only to achieve the desired aesthetic result but also to control postoperative complications.